Skip to content

Clinical trials

Phase 2 Anemia, Refractory, with Excess of Blasts trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Phase: Phase 2 Country / region: United States Clear all

110 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20018
20024
20035
20047
20056
20066
20076
20082
20096
20105
20112
20124
20132
20142
20152
20161
20172
20183
20191
20201
20222
20232
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71
Terminated16
Recruiting12
Unknown status5
Active, not recruiting4
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center14
National Cancer Institute (NCI)9
Masonic Cancer Center, University of Minnesota7
Memorial Sloan Kettering Cancer Center6
M.D. Anderson Cancer Center5
Case Comprehensive Cancer Center4
National Heart, Lung, and Blood Institute (NHLBI)4
Roswell Park Cancer Institute4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
David Rizzieri, MD3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts110
Myelodysplastic Syndromes73
Leukemia60
Leukemia, Myeloid, Acute59
Leukemia, Myelomonocytic, Chronic55
Precursor Cell Lymphoblastic Leukemia-Lymphoma47
Anemia, Refractory45
Myeloproliferative Disorders33
Leukemia, Lymphocytic, Chronic, B-Cell27
Congenital Abnormalities26

Trials

Showing 1 to 25 of 110. Each trial links to its page on Pharma Observatory.

10 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.